Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pierratos, A.
Right arrow Articles by Uldall, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pierratos, A.
Right arrow Articles by Uldall, R.

Journal of the American Society of Nephrology, Vol 9, 859-868, Copyright © 1998 by American Society of Nephrology


REGULAR ARTICLES

Nocturnal hemodialysis: three-year experience

A Pierratos, M Ouwendyk, R Francoeur, S Vas, DS Raj, AM Ecclestone, V Langos and R Uldall
Wellesley Central Hospital, Toronto, Ontario, Canada.

There is evidence that high frequency, as well as long duration, hemodialysis provides better clinical outcomes. We developed nocturnal hemodialysis, a new innovative form of renal replacement therapy, which is performed six to seven nights per week for 8 to 10 h during sleep at home. Blood flow was set at 300 ml/min and dialysate flow at 100 ml/min. An internal jugular catheter was used as the vascular access. Special precautions were taken to prevent accidental disconnection during sleep, as well as air embolization. Dialysis functions from the patient's home were monitored continuously via a modem at the nocturnal hemodialysis center. Twelve patients have completed training and have been successfully performing nocturnal hemodialysis for up to 34 mo. This study represents 170 patient months of experience accumulated over 3 yr. There was hemodynamic stability and significant subjective improvement in patient well being. Nightly Kt/V was 0.99. Weekly removal of phosphate was twice as high and beta2 microglobulin 4 times as high as conventional hemodialysis. All patients have discontinued their phosphate binders and have increased dietary phosphate and protein intake. BP control was achieved with fewer medications. Dialyzer reuse has decreased the operating costs to the level of the other form of home dialysis. Complications were infrequent and were related primarily to the dialysis access. Nocturnal hemodialysis represents the most efficient form of dialysis at low cost and should be considered as an option for patients who can be trained for home hemodialysis.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Davenport, C. Gardner, M. Delaney, and on behalf of the Pan Thames Renal Audit Group
The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit
Nephrol. Dial. Transplant., October 28, 2009; (2009) gfp560v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. P. Pauly, J. S. Gill, C. L. Rose, R. A. Asad, A. Chery, A. Pierratos, and C. T. Chan
Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2915 - 2919.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. David, P. Kumpers, G. M. Eisenbach, H. Haller, and J. T. Kielstein
Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2232 - 2240.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
R. P. Pauly, M. Copland, P. Komenda, A. Levin, A. Pierratos, and C. T. Chan
Utility and Limitations of a Multicenter Nocturnal Home Hemodialysis Cohort
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1846 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Jean, C. Chazot, and B. Charra
Hyperphosphataemia and related mortality
Nephrol. Dial. Transplant., February 1, 2006; 21(2): 273 - 280.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. T. Chan, S. H. Li, and S. Verma
Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F679 - F684.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. D. Kloppenburg, C. A. Stegeman, T. K. Kremer Hovinga, G. Vastenburg, P. Vos, P. E. de Jong, and R. M. Huisman
Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1212 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. B. McCormick, A. Pierratos, S. Fenton, V. Jain, J. Zaltzman, and C. T. Chan
Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation
Nephrol. Dial. Transplant., March 1, 2004; 19(3): 714 - 719.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
V. E. Andreucci, D. N. S. Kerr, and J. D. Kopple
Rights of chronic renal failure patients undergoing chronic dialysis therapy
Nephrol. Dial. Transplant., January 1, 2004; 19(1): 30 - 38.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. T. Chan, P. J. Harvey, P. Picton, A. Pierratos, J. A. Miller, and J. S. Floras
Short-Term Blood Pressure, Noradrenergic, and Vascular Effects of Nocturnal Home Hemodialysis
Hypertension, November 1, 2003; 42(5): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Al-Hejaili, C. Kortas, R. Leitch, A. P. Heidenheim, L. Clement, G. Nesrallah, and R. M. Lindsay
Nocturnal but not Short Hours Quotidian Hemodialysis Requires an Elevated Dialysate Calcium Concentration
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2322 - 2328.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. K. Leypoldt, B. L. Jaber, M. J. Lysaght, J. T. McCarthy, and J. Moran
Kinetics and dosing predictions for daily haemofiltration
Nephrol. Dial. Transplant., April 1, 2003; 18(4): 769 - 776.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Chan, J. S. Floras, J. A. Miller, and A. Pierratos
Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure
Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1518 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J.-P. Gutzwiller, D. Schneditz, A. R. Huber, C. Schindler, F. Gutzwiller, and C. E. Zehnder
Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1037 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
W. H. Horl
Secondary hyperparathyroidism: present and future therapeutic implications
Nephrol. Dial. Transplant., May 1, 2002; 17(5): 732 - 733.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. N. Friedman, A. G. Bostom, A. S. Levey, I. H. Rosenberg, J. Selhub, and A. Pierratos
Plasma Total Homocysteine Levels among Patients Undergoing Nocturnal versus Standard Hemodialysis
J. Am. Soc. Nephrol., January 1, 2002; 13(1): 265 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. M. Chertow
""Wishing Don't Make it So""--Why We Need a Randomized Clinical Trial of High-Intensity Hemodialysis
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2850 - 2853.
[Full Text] [PDF]


Home page
NEJMHome page
P. J. Hanly and A. Pierratos
Improvement of Sleep Apnea in Patients with Chronic Renal Failure Who Undergo Nocturnal Hemodialysis
N. Engl. J. Med., January 11, 2001; 344(2): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. S. C. Raj, M. Ouwendyk, R. Francoeur, and A. Pierratos
{beta}2-Microglobulin kinetics in nocturnal haemodialysis
Nephrol. Dial. Transplant., January 1, 2000; 15(1): 58 - 64.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Pierratos
Nocturnal home haemodialysis: an update on a 5-year experience
Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2835 - 2840.
[Full Text] [PDF]


Home page
BMJHome page
E A. Balas and I. Iakovidis
Distance technologies for patient monitoring
BMJ, November 13, 1999; 319(7220): 1309 - 1309.
[Full Text]


Home page
CMAJHome page
A. Pierratos
Nocturnal hemodialysis: dialysis for the new millennium
Can. Med. Assoc. J., November 1, 1999; 161(9): 1137 - 1137.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Agroyannis, C. Fourtounas, H. Tzanatos, and I. Kopelias
Can telemedicine contribute to the expansion of home haemodialysis?
Nephrol. Dial. Transplant., January 1, 1999; 14(1): 251 - 252.
[PDF]


Home page
NEJMHome page
R. G. Luke
Chronic Renal Failure -- A Vasculopathic State
N. Engl. J. Med., September 17, 1998; 339(12): 841 - 843.
[Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP